Actively Recruiting
Evaluation of Growth and Tolerance for a New Extensively Hydrolyzed Casein Infant Formula Compared to a Commercially Available Formula
Led by Mead Johnson Nutrition · Updated on 2026-10-20
214
Participants Needed
12
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
This research evaluates the growth and tolerance of infants consuming a new extensively hydrolyzed cow milk protein formula compared to a currently marketed extensively hydrolyzed cow milk protein formula. The study focuses on healthy, term infants aged approximately 10 to 14 days at enrollment, aiming to show that the investigational formula supports typical growth and is well tolerated. Secondary goals include examining feeding tolerance, stool characteristics, intake amounts, and any health issues arising during the study. Participants will be randomly assigned to receive either the investigational extensively hydrolyzed casein formula made with a new manufacturing process or a commercially available extensively hydrolyzed casein formula. Both formulas have the same nutritional content per 100 kcal. The study formula feeding will continue through approximately 126 days of age. During the study, infants growth measurements such as weight gain, body length, and head circumference will be tracked up to 131 days of age. Researchers will also monitor stool characteristics, formula intake, tolerance signs like spit-up or fussiness, and any medically confirmed adverse events. Caregivers will be supported with remote visits and assessments, including the use of reliable internet for study participation.
CONDITIONS
Brief Title
Extensively Hydrolyzed Formula Growth Monitioring Study (GMS)
Research Team
A
Amy Benson
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here